ADIM
HZO icon

Alpha DNA Investment Management’s MarineMax HZO Stock Holding History

Alpha DNA Investment Management’s Portfolio HZO Stock Details HZO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-29,496
Closed -$1.43M – 123
2021
Q3 		$1.43M Buy
29,496
+1,141
+4% +$56.9K 0.97% 46
2021
Q2 		$1.38M Buy
28,355
+15,658
+123% +$817K 0.94% 71
2021
Q1 		$626K Buy
+12,697
New +$599K 0.72% 68

Other funds holding HZO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Alpha DNA Investment Management's HZO Position: Q4 2021 in Review

Alpha DNA Investment Management sold out of MarineMax (HZO) in Q4 2021, closing a stake of 29,496 shares — an estimated $1.43M sold.

Alpha DNA Investment Management first reported a position in HZO in Q1 2021 and held it in 3 quarters. The position peaked at $1.43M in Q3 2021. 234 funds tracked by Wall St. Rank hold HZO as of Q4 2021.

  • Alpha DNA Investment Management reported no remaining MarineMax position as of Q4 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 29,496 MarineMax shares in Q4 2021, an estimated $1.43M.
  • Alpha DNA Investment Management first reported a position in MarineMax in Q1 2021 and held it in 3 quarters.
  • Alpha DNA Investment Management's MarineMax position peaked at $1.43M in Q3 2021.
  • 234 funds tracked by Wall St. Rank held MarineMax as of Q4 2021.

Based on Alpha DNA Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.